These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 6588249)

  • 1. Ratio of parathyroid hormone to 1,25-dihydroxycholecalciferol in early renal failure.
    Lucas PA; Brown RC; Woodhead JS; Coles GA
    Kidney Int Suppl; 1983 Dec; 16():S171-4. PubMed ID: 6588249
    [No Abstract]   [Full Text] [Related]  

  • 2. Skeletal lesions and calcium metabolism in early renal failure.
    Malluche HH; Ritz E; Hodgson M; Kutschera J; Krause G; Seiffert U; Gati A; Lange HP
    Proc Eur Dial Transplant Assoc; 1975; 11():443-50. PubMed ID: 1197269
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin in chronic renal failure.
    Franck H; Keck E; Issa S; Krüskemper HL; von Lilienfeld-Toal H
    Exp Clin Endocrinol; 1988 May; 91(2):202-6. PubMed ID: 3409970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term effects of renal transplantation on the metabolism of vitamin D3.
    Saha H; Salmela K; Ahonen J; Pietilä K; Mörsky P; Pasternack A
    Transplant Proc; 1992 Feb; 24(1):367-8. PubMed ID: 1539320
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of high-dose glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects.
    Nielsen HK; Thomsen K; Eriksen EF; Charles P; Storm T; Mosekilde L
    Bone Miner; 1988 Apr; 4(1):105-13. PubMed ID: 3263890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Levels of plasma 1,25-dihydroxyvitamin D and parameters of phospho-calcium metabolism in children with non-dialyzed chronic renal failure].
    Loras B; Parchoux B; Durr F
    Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():755-60. PubMed ID: 6897703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct impact of vitamin D insufficiency on calcitriol levels in chronic renal failure and renal transplant patients: a role for FGF23.
    Mazzaferro S; Pasquali M; Pugliese F; Citterio F; Gargiulo A; Rotondi S; Tartaglione L; Conte C; Pirrò G; Taggi F
    J Nephrol; 2012; 25(6):1108-18. PubMed ID: 22383345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of mineral metabolism derangements in childhood chronic renal failure.
    Bianchi ML; Claris-Appiani A; Romeo L; Soldati L; Marra G; Bini P; Ortolani S
    Bone Miner; 1986 Dec; 1(6):475-83. PubMed ID: 3504718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin K status in relation to bone metabolism in patients with renal failure.
    Małyszko J; Wołczyński S; Skrzydlewska E; Małyszko JS; Myśliwiec M
    Am J Nephrol; 2002; 22(5-6):504-8. PubMed ID: 12381951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bone-renal axis in early chronic kidney disease: an emerging paradigm.
    Danziger J
    Nephrol Dial Transplant; 2008 Sep; 23(9):2733-7. PubMed ID: 18469306
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of fibroblast growth factor-23 in chronic kidney disease.
    Westerberg PA; Linde T; Wikström B; Ljunggren O; Stridsberg M; Larsson TE
    Nephrol Dial Transplant; 2007 Nov; 22(11):3202-7. PubMed ID: 17567652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis.
    Gkonos PJ; London R; Hendler ED
    N Engl J Med; 1984 Dec; 311(26):1683-5. PubMed ID: 6548798
    [No Abstract]   [Full Text] [Related]  

  • 14. 1,25(OH)2D3 and 25-OHD3 in the treatment of renal osteodystrophy: comparison of combined versus 1,25(OH)2D3 administration alone.
    Coen G; Taccone Gallucci M; Bonucci E; Ballanti P; Bianchi AR; Bianchini G; Matteucci MC; Mazzaferro S; Picca S; Taggi F; Cinotti GA; Casciani CU
    Miner Electrolyte Metab; 1983; 9(1):19-27. PubMed ID: 6687749
    [No Abstract]   [Full Text] [Related]  

  • 15. Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3.
    Madsen S
    Acta Med Scand Suppl; 1980; 638():3-120. PubMed ID: 6929650
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
    Zisman AL; Hristova M; Ho LT; Sprague SM
    Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Parathyroid hormone and calcitonin in chronic kidney failure].
    Okazaki R; Matsumoto T
    Nihon Rinsho; 1992 Jan; 50 Suppl():600-5. PubMed ID: 1578744
    [No Abstract]   [Full Text] [Related]  

  • 18. Parathyroid function in mild to moderate renal failure: evaluation by oral calcium suppression test.
    St John A; Thomas M; Dick I; Young P; Prince RL
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1436-8. PubMed ID: 8200947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosing hypovitaminosis D: serum measurements of calcium, phosphate, and alkaline phosphatase are unreliable, even in the presence of secondary hyperparathyroidism.
    Smith GR; Collinson PO; Kiely PD
    J Rheumatol; 2005 Apr; 32(4):684-9. PubMed ID: 15801026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Early treatment of secondary hyperparathyroidism in moderate renal insufficiency: low-phosphorus diet versus calcium carbonate].
    Aresté N; Amor J; Cambil T; Salgueira M; Sánchez-Palencia R; Páez C; Gómez O; Palma A
    Nefrologia; 2003; 23 Suppl 2():64-8. PubMed ID: 12778857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.